Bryan, Garnier & Co's News

GlaxoSmithKline: Mepolizumab recommended for approval in Europe

NEUTRAL, Fair Value 1520p vs. 1470p (+21%)
News published on
September Friday 25, 2015


For more information, please contact marketing@bryangarnier.com